Tumor biomarkers may help doctors decide on best therapy for lung cancer patients, according to a study conducted by researchers at The University of Texas M.D. Anderson Cancer Center.
Two studies demonstrate how scientists have taken steps forward in the understanding of ovarian cancer.
Researchers have designed a new anticancer agent that targets the survival mechanism of cancer cells, according to a report published in the Journal of Biological Chemistry (2010;285(16):9780-9791).
When used in combination, two targeted therapies significantly inhibit tumor growth in gastric cancer, according to a study published in the journal Clinical Cancer Research (2010 Mar 1;16(5):1509-19).
